mKG treatment significantly decreased pulmonary alveolitis, fibrosis scores, hydroxyprolines, Col-1, Col-3 contents, IL-6, IL-17, and TGF-β in BLM-induced lung tissues [222]. The gene discussed is IL17A; the disease is fibrosis.